Clinical Trial Update: Safety, Tolerability and PK/PD of JMT103 in Patients With Bone Metastases From Tumors [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update assessing safety, tolerability and PK/PD of JMT103 in patients with bone metastases from tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Metastases

Drugs mentioned

• JMT103

Snippet

Sponsor: Shanghai JMT-Bio Inc. | Conditions: Bone Metastases | Phase 1 | Status: UNKNOWN